Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Kairos Pharma, Ltd. reported a net loss of $5.03 million for the nine months ended September 30, 2026, compared to a $4.08 million loss in the prior year period. The company remains in the development stage with no revenue, and its cash position decreased to $3.13 million as of September 30, 2026, from $4.49 million at year-end 2025.
Cerenome, Inc. reported a net loss of $24.6 million for the nine months ended September 30, 2026, compared to a $16.7 million loss in the prior year period. While the company introduced diagnostic revenue of $0.7 million, total revenue decreased due to lower grant revenue, and operating expenses nearly doubled to $25.8 million.
Beasley Broadcast Group reported third quarter 2026 net revenue of $42.8 million, a 16.1% decrease year-over-year driven by weakness in national and local agency advertising. The company reported a net loss of $12.1 million for the quarter but highlighted improved digital operating margins of 32% and the completion of asset sales generating over $10 million in proceeds subsequent to quarter-end.
Health In Tech reported Q3 2026 revenue of $6.6 million and a net loss of $7.1 million, which included a $5.3 million provision for credit losses. The company highlighted a 15.9% year-over-year growth in distribution partners and a revenue pipeline of $156.4 million as of late October.
Term
Q3 2026
“It is a privilege to lead Health In Tech into its next chapter, and I want to thank Tim Johnson, our founder and Executive Chairman, and the Board for their confidence. Throughout my career, I have focused on scaling businesses, developing growth strategies, and leveraging capital markets to support long-term value creation. I have substantial operational experience scaling new products from incubation to meaningful commercial scale, building”
Sanjay Shrestha, Chief Executive Officer of Health In Tech
Cheetah Net Supply Chain Service Inc. reported a significant increase in revenue to $4.52 million for the nine months ended September 30, 2026, compared to $1.20 million in the prior year. Despite this growth, the company realized a net loss of $3.09 million, driven by high operating expenses and a $2.78 million loss related to the change in fair value of an acquisition-related contingent consideration asset.
Healthcare Triangle, Inc. reported a significant revenue increase to $28.2 million for the nine months ended September 30, 2026, compared to $10.8 million in the prior year, driven by business expansion. However, the company continues to operate at a loss, with a net loss from operations of $9.7 million for the period and a total asset base that grew to $72.7 million following substantial increases in intangible assets.
Fly-E Group, Inc. reported a significant decline in revenue to $5.34 million for the six months ended September 30, 2026, compared to $9.24 million in the prior year period. The company's net loss widened to $5.68 million for the same period, driven by decreased gross profit and high general and administrative expenses, raising concerns about its ability to continue as a going concern.
Presidio Property Trust reported a decrease in total revenue to $10.57 million for the nine months ended September 30, 2026, compared to $12.70 million in the prior year period. The company experienced a significant reduction in total assets from $122.1 million at year-end 2025 to $86.3 million, primarily driven by a decrease in real estate assets held for investment.
Scientific Industries reported a net loss of $2.35 million for the nine months ended September 30, 2026, compared to a net income of $0.69 million in the prior year period. While revenues increased to $4.05 million from $3.43 million, the prior year's profitability was primarily driven by a larger gain on the disposition of discontinued operations.
Mobiquity Technologies reported a significant revenue increase to $334,896 for the nine months ended September 30, 2026, compared to $160,795 in the prior year. However, net loss widened to $8.6 million due to higher general and administrative expenses, resulting in a total stockholders' deficit of $221,189.
Positron Corp filed its Form 10-Q for the quarterly period ended September 30, 2026, detailing its financial performance and operational progress in the molecular imaging industry. The report highlights the company's focus on its PET imaging systems and the development of its radiopharmaceutical business segments.
Calidi Biotherapeutics reported a net loss of $11.9 million for the nine months ended September 30, 2026, compared to a $16.0 million loss in the prior year period. The company maintained a cash balance of $3.9 million as of September 30, 2026, and completed a 1-for-16 reverse stock split in July 2026 to adjust its capital structure.
EQT Private Equity Company LLC reported total investments at fair value of $997.7 million as of September 30, 2026, representing a significant increase from $602.9 million at the end of 2025. The company maintains a diverse share structure across multiple classes and reported $165.6 million in cash and cash equivalents to support its ongoing private equity acquisition strategy.
Stardust Power Inc. reported total assets of $13.4 million and total liabilities of $15.4 million as of September 30, 2026, resulting in a stockholders' deficit. The company faces substantial doubt regarding its ability to continue as a going concern following its delisting from Nasdaq and transition to the Pink Limited Market.
Guru App Factory Corp reported a decline in revenue from $94,500 in 2025 to $52,000 in 2026, primarily due to the non-recurrence of a large software development order. The company's net loss widened to $59,440, and its independent auditor issued a going concern warning due to a working capital deficit and accumulated deficit of $126,863.
Highview Merger Corp. reported a net income of $5.37 million for the nine months ended September 30, 2026, primarily driven by $6.24 million in interest earned on marketable securities held in the Trust Account. As a shell company, its activities are focused on identifying a target for a business combination, with $239.85 million currently held in trust for potential redemptions.
EQT Infrastructure Company LLC reported total investments at fair value of $886.6 million as of September 30, 2026, a significant increase from zero at the end of 2025 following its initial offering in February 2026. The company maintains a complex share structure with over 44 million shares outstanding across various classes, primarily focused on acquiring and managing portfolio companies through joint ventures.
Twelve Seas Investment Company III is a shell company that completed its IPO on December 15, 2025, raising $172.5 million held in trust. As of September 30, 2026, the company has 17,745,000 Class A and 5,692,500 Class B ordinary shares outstanding and is seeking a business combination within a 24-month window ending December 15, 2027.
Beyond Air reported record quarterly revenue of $2.3 million for the period ended September 30, 2026, representing 28% year-over-year growth. The company reaffirmed its revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027 while awaiting FDA approval for its second-generation LungFit PH system.
Term
Q2 2027
“Building on the commercial momentum we are generating with our first-generation LungFit PH system, we believe our second-generation system has the potential to substantially expand our market opportunity and accelerate growth, pending FDA approval.”
Robert Goodman, Chief Executive Officer of Beyond Air
“We remain encouraged by our active and productive discussions with the FDA and the progress we are making toward completing the remaining steps in the review process for the second-generation LungFit PH system.”
Robert Goodman, Chief Executive Officer of Beyond Air
Spruce Power Holding Corp reported 19,294,133 shares of common stock outstanding as of November 9, 2026. The company's cash and cash equivalents decreased from $54.8 million at the end of 2025 to $40.1 million as of September 30, 2026, while management highlighted risks related to debt refinancing and solar industry demand.
Evofem Biosciences reported Q3 2026 financial results, achieving $0.7 million in operating income despite a slight decline in net sales to $4.6 million. The company highlighted the shipment of its 500,000th box of PHEXX and the addition of a fifth study site for an NIH-funded Phase 4 trial of SOLOSEC.
Term
Q3 2026
“While third quarter net sales reflect the cumulative impact of operating without dedicated growth capital for brand promotion and physician outreach since late 2022, we are proud of the discipline, efficiency and tenacity demonstrated across the organization. Through rigorous expense management, we generated $0.7 million of operating income during the quarter while continuing to support patients and healthcare providers who rely on our innovative sexual health products.”
BioScience Health Innovations, Inc. reported a net loss of $564,885 for the nine months ended September 30, 2026, a significant decline from the $875,720 net income in the prior year period. Despite the loss, the company successfully raised over $2 million through common stock sales, ending the period with a strengthened cash position of $1,691,858.
KKR Private Equity Conglomerate LLC reported a net increase in net assets resulting from operations of $975.5 million for the nine months ended September 30, 2026, compared to $762.1 million in the prior year period. Total assets grew to $13.6 billion, driven by a significant increase in investments at fair value and cash holdings.
Evofem Biosciences reported a significant decline in total assets from $20.3 million at year-end 2025 to $7.3 million as of September 30, 2026, driven largely by a decrease in trade accounts receivable and intangible assets. The company faces substantial liquidity challenges with $84.8 million in current liabilities and has received notices of default from Future Pak, LLC regarding its debt obligations.
Senior Credit Investments, LLC reported a net increase in member’s capital resulting from operations of $18.4 million for the nine months ended September 30, 2026, up from $12.0 million in the prior year period. Total investment income grew significantly to $40.4 million, driven by interest income from its non-controlled/non-affiliated investment portfolio, while net asset value per unit decreased slightly to $1,767.94 from $1,787.98 at year-end 2025.
Jefferies Credit Partners BDC Inc. reported a net increase in net assets resulting from operations of $52.0 million for the nine months ended September 30, 2026, compared to $30.5 million for the same period in 2025. Total net assets grew to $964.9 million from $677.0 million at year-end 2025, driven by significant capital share issuances and investment income growth.
The 21Shares Solana Staking ETF reported net assets of $9,786,070 as of September 30, 2026, a significant increase from $5,735,019 at the end of 2025. The Trust generated $102,143 in staking rewards for the nine months ended September 30, 2026, and transitioned its pricing benchmark to the FTSE Solana Index in August 2026.
Blue Line Holdings, Inc. remains a pre-revenue industrial company with a net loss of $12,459 for the quarter ended September 30, 2026. The company reported a working capital deficit of $90,521 and expressed substantial doubt regarding its ability to continue as a going concern without additional financing.
For the quarter ended September 30, 2026, INVE Technologies reported a net income of $0.6 million, a significant improvement from a $3.5 million loss in the prior year, primarily driven by a $6.1 million gain on an asset sale. However, total revenue decreased to $3.1 million from $5.0 million year-over-year, and the company recorded a nine-month net loss of $7.5 million.
Femasys Inc. reported a decrease in sales for the nine months ended September 30, 2026, totaling $1,161,313 compared to $1,479,926 in the prior year period. The company significantly strengthened its balance sheet, ending the quarter with $23.9 million in cash and cash equivalents following financing activities, while maintaining an accumulated deficit of $154 million.